We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bioequivalence, Chemistry Gaps Top Out FDA ANDA Refusals
Bioequivalence, Chemistry Gaps Top Out FDA ANDA Refusals
October 4, 2013
Most ANDAs rejected by the FDA have deficiencies with either submitted chemistry or bioequivalence data, new draft guidance on the agency’s “refuse-to-receive” standard states.